{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:27:35Z","timestamp":1761017255911,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00228-018-02618-5","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T20:49:54Z","timestamp":1546548594000},"page":"599-601","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["HLA-B*5701 and HLA-B*5801 in an Indian patient with anti-epileptics induced cutaneous adverse drug reactions"],"prefix":"10.1007","volume":"75","author":[{"given":"Aarthi","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2129-121X","authenticated-orcid":false,"given":"Ajay Sam","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambujam","family":"Sreedevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna Devi","family":"Sathishkannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhargav Kiran","family":"Gaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"2618_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","volume":"28","author":"A Sidoroff","year":"2001","unstructured":"Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC (2001) Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol 28:113\u2013119","journal-title":"J Cutan Pathol"},{"key":"2618_CR2","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","volume":"364","author":"P Chen","year":"2011","unstructured":"Chen P, Lin J-J, Lu C-S, Ong C-T, Hsieh PF, Yang C-C et al (2011) Carbamazepine-induced toxic effects and HLA-B* 1502 screening in Taiwan. N Engl J Med 364:1126\u20131133. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1009717","journal-title":"N Engl J Med"},{"key":"2618_CR3","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, for the JSAR research group (2010) HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 51:2461\u20132465. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02766.x","journal-title":"Epilepsia"},{"key":"2618_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","volume":"51","author":"H Ikeda","year":"2010","unstructured":"Ikeda H, Takahashi Y, Yamazaki E, Fujiwara T, Kaniwa N, Saito Y, Aihara M, Kashiwagi M, Muramatsu M (2010) HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions. Epilepsia 51:297\u2013300. \n                    https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02269.x","journal-title":"Epilepsia"},{"key":"2618_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3343\/alm.2014.34.5.372","volume":"34","author":"JS Song","year":"2014","unstructured":"Song JS, Kang E-S, Joo EY, Hong SB, Seo D-W, Lee S-Y (2014) Absence of HLA-B*1502 and HLA-A*3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study. Ann Lab Med 34:372\u2013375. \n                    https:\/\/doi.org\/10.3343\/alm.2014.34.5.372","journal-title":"Ann Lab Med"},{"key":"2618_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/clpt.2013.55","volume":"94","author":"U Amstutz","year":"2013","unstructured":"Amstutz U, Ross CJD, Castro-Pastrana LI, Rieder MJ, Shear NH, Hayden MR, Carleton BC, CPNDS Consortium (2013) HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children. Clin Pharmacol Ther 94:142\u2013149. \n                    https:\/\/doi.org\/10.1038\/clpt.2013.55","journal-title":"Clin Pharmacol Ther"},{"key":"2618_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/pgs.09.162","volume":"11","author":"S-I Hung","year":"2010","unstructured":"Hung S-I, Chung W-H, Liu Z-S, Chen C-H, Hsih M-S, Hui RC, Chu CY, Chen YT (2010) Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 11:349\u2013356. \n                    https:\/\/doi.org\/10.2217\/pgs.09.162","journal-title":"Pharmacogenomics"},{"key":"2618_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal S, Phillips E, Carosi G, Molina J-M, Workman C, Tomazic J, J\u00e4gel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A, PREDICT-1 Study Team (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568\u2013579. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0706135","journal-title":"N Engl J Med"},{"issue":"15960","key":"2618_CR9","doi-asserted-by":"publisher","first-page":"15960","DOI":"10.1038\/s41598-017-15965-7","volume":"7","author":"C Kannabiran","year":"2017","unstructured":"Kannabiran C, Ueta M, Sangwan V, Rathi V, Basu S, Tokunaga K, Kinoshita S (2017) Association of human leukocyte antigen class 1 genes with Stevens Johnson syndrome with severe ocular complications in an Indian population. Sci Rep 7(15960):15960. \n                    https:\/\/doi.org\/10.1038\/s41598-017-15965-7","journal-title":"Sci Rep"},{"key":"2618_CR10","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, Ikezawa Z, Iijima M, Shiohara T, Hashimoto K, Kamatani N, Nakamura Y (2011) Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet 20:1034\u20131041. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddq537","journal-title":"Hum Mol Genet"},{"key":"2618_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jama.2014.7859","volume":"312","author":"W-H Chung","year":"2014","unstructured":"Chung W-H, Chang W-C, Lee Y-S, Wu Y-Y, Yang C-H, Ho H-C, Chen MJ, Lin JY, Hui RC, Ho JC, Wu WM, Chen TJ, Wu T, Wu YR, Hsih MS, Tu PH, Chang CN, Hsu CN, Wu TL, Choon SE, Hsu CK, Chen DY, Liu CS, Lin CY, Kaniwa N, Saito Y, Takahashi Y, Nakamura R, Azukizawa H, Shi Y, Wang TH, Chuang SS, Tsai SF, Chang CJ, Chang YS, Hung SI, Taiwan Severe Cutaneous Adverse Reaction Consortium, Japan Pharmacogenomics Data Science Consortium (2014) Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 312:525\u2013534. \n                    https:\/\/doi.org\/10.1001\/jama.2014.7859","journal-title":"JAMA"},{"issue":"3","key":"2618_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","volume":"14","author":"E Genin","year":"2014","unstructured":"Genin E, Chen D-P, Hung S-I, Sekula P, Schumacher M, Chang P-Y, Tsai SH, Wu TL, Bell\u00f3n T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH, Mockenhaupt M, Roujeau JC (2014) HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenomics J 14(3):281\u2013288. \n                    https:\/\/doi.org\/10.1038\/tpj.2013.40","journal-title":"Pharmacogenomics J"},{"key":"2618_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2125.2009.03578.x","volume":"69","author":"A Li-Wan-Po","year":"2010","unstructured":"Li-Wan-Po A, Girard T, Farndon P, Farndon P, Cooley C, Lithgow J (2010) Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17. Br J Clin Pharmacol 69:222\u2013230. \n                    https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03578.x","journal-title":"Br J Clin Pharmacol"},{"key":"2618_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jpba.2005.02.045","volume":"39","author":"KM Patil","year":"2005","unstructured":"Patil KM, Bodhankar SL (2005) Simultaneous determination of lamotrigine, phenobarbitone, carbamazepine and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal 39:181\u2013186. \n                    https:\/\/doi.org\/10.1016\/j.jpba.2005.02.045","journal-title":"J Pharm Biomed Anal"},{"key":"2618_CR15","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1177\/106002809302701114","volume":"27","author":"G Hayes","year":"1993","unstructured":"Hayes G, Kootsikas ME (1993) Reassessing the lower end of the phenytoin therapeutic range: a review of the literature. Ann Pharmacother 27:1389\u20131392. \n                    https:\/\/doi.org\/10.1177\/106002809302701114","journal-title":"Ann Pharmacother"},{"key":"2618_CR16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1081\/CLT-120015836","volume":"40","author":"RI Winnicka","year":"2002","unstructured":"Winnicka RI, Topaci\u0144ski B, Szymczak WM, Szyma\u0144ska B (2002) Carbamazepine poisoning: elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide. J Toxicol Clin Toxicol 40:759\u2013765","journal-title":"J Toxicol Clin Toxicol"},{"key":"2618_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2013.00012","volume":"4","author":"K Klein","year":"2013","unstructured":"Klein K, Zanger UM (2013) Pharmacogenomics of cytochrome P450 3A4: recent progress toward the \u201cmissing heritability\u201d problem. Front Genet 4:12. \n                    https:\/\/doi.org\/10.3389\/fgene.2013.00012","journal-title":"Front Genet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-02618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-018-02618-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-018-02618-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T19:05:30Z","timestamp":1578078330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-018-02618-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2618"],"URL":"https:\/\/doi.org\/10.1007\/s00228-018-02618-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,1,4]]},"assertion":[{"value":"4 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in the study involving human participant were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the participant involved in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}